Intellicell Biosciences Inc (fka SVFC)

[cazual]

Quote: "I believe that with the use of cavitation technology to harvest the stromal vascular fraction from a lipoaspirate without chemicals and enzymes, we would be able to capture the appropriate stem cells with their micromatrix and microenvironment for use in patients with failing hearts and lungs."

In his research role at the UA, he is the director of the Ex Vivo Lung Program, clinical and translational research, and the Cardiopulmonary Stem Cell Bank. Dr. Khalpey also holds a position on the UA Institutional Review Board (IRB).

He also is involved in creating clinical “bridge-to-regeneration” trials, in which autologous stem cells will be injected into failing hearts with the hope of recovery in an era of limited hearts for transplantation.

http://marketwatch.com/story/intellicell-biosciences-announces-that-dr-zain-khalpey-has-joined-its-advisory-board-2013-06-17

http://opa.ahsc.arizona.edu/newsroom/news/2013/heart-surgeon-zain-khalpey-appointed-lead-heart-transplant-program-mechanical-cir